• ქართული
  • English
  • Biogen first-quarter profit rises 20 percent on Spinraza strength

    Drugmaker Biogen Inc reported a 20 percent rise in first-quarter profit on Wednesday, driven by higher sales of its muscle disease treatment Spinraza.

    Market Quotes by TradingView